Search results
Results From The WOW.Com Content Network
In more modern times, research surrounding attention disorders has traditionally focused on hyperactive symptoms, but began to newly address inattentive symptoms in the 1970s. Influenced by this research, the DSM-III (1980) allowed for the first time a diagnosis of an ADD subtype that presented without hyperactivity.
Bradyphrenia is the slowness of thought common to many disorders of the brain. [1] Disorders characterized by bradyphrenia include Parkinson's disease and forms of schizophrenia consequently causing a delayed response and fatigue. [2]
Sensory processing disorder; Other names: Sensory integration dysfunction: An SPD nosology proposed by Miller LJ et al. (2007) [1] Specialty: Psychiatry, occupational therapy, neurology: Symptoms: Hypersensitivity and hyposensitivity to stimuli, and/or difficulties using sensory information to plan movement. Problems discriminating ...
These symptoms might look like this: “Forgetting a recent conversation or starting to lose things like keys, glasses, or phone—and not just once,” McKay says.
Learning disability, learning disorder, or learning difficulty (British English) is a condition in the brain that causes difficulties comprehending or processing information and can be caused by several different factors. Given the "difficulty learning in a typical manner", this does not exclude the ability to learn in a different manner.
Cognitive impairment is an inclusive term to describe any characteristic that acts as a barrier to the cognition process or different areas of cognition. [1] Cognition, also known as cognitive function, refers to the mental processes of how a person gains knowledge, uses existing knowledge, and understands things that are happening around them using their thoughts and senses. [2]
Having decreased or damaged white matter can slow the brain’s ability to process information. Overall, “it shows us that brain ageing at age 73 is not an inevitability, while also strongly ...
Researchers found that when the device was aimed at the right spot in the brain, it could slow the development of symptoms, such as memory loss, compared to an inactive treatment.